Matches in Wikidata for { <http://www.wikidata.org/entity/Q69906539> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q69906539 description "artículu científicu espublizáu n'ochobre de 1987" @default.
- Q69906539 description "im Oktober 1987 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69906539 description "scientific article published on 01 October 1987" @default.
- Q69906539 description "wetenschappelijk artikel" @default.
- Q69906539 description "наукова стаття, опублікована в жовтні 1987" @default.
- Q69906539 name "SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years" @default.
- Q69906539 name "SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years" @default.
- Q69906539 type Item @default.
- Q69906539 label "SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years" @default.
- Q69906539 label "SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years" @default.
- Q69906539 prefLabel "SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years" @default.
- Q69906539 prefLabel "SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years" @default.
- Q69906539 P1433 Q69906539-F128C59A-45CD-4267-AC39-1763C9FBCE84 @default.
- Q69906539 P1476 Q69906539-91033277-6BCA-4609-B352-FC48C69E43AC @default.
- Q69906539 P2093 Q69906539-13CC8681-165E-49B1-86B3-445496A88467 @default.
- Q69906539 P2093 Q69906539-A95D8031-326F-4314-9140-87FE7A911466 @default.
- Q69906539 P2093 Q69906539-CDB1A293-35A2-43C2-B538-E291FD8B7E00 @default.
- Q69906539 P304 Q69906539-0C617B17-8BAE-469C-B847-93BC6DA2FF52 @default.
- Q69906539 P31 Q69906539-8C71B60F-9C4F-47BC-A2BD-669895AF01D9 @default.
- Q69906539 P356 Q69906539-D851C27F-19F5-4304-BE85-5ADB19AF04EE @default.
- Q69906539 P407 Q69906539-55CA4077-82F5-457B-941D-EC991496BB3F @default.
- Q69906539 P433 Q69906539-C62D62C2-D216-4FB9-A002-124D4ADAB608 @default.
- Q69906539 P478 Q69906539-3788AE87-874C-439E-802C-F0A6EDA230B3 @default.
- Q69906539 P577 Q69906539-FEAF7E28-C0AD-4A31-B1E5-752F85D64AD3 @default.
- Q69906539 P698 Q69906539-C0F73ACA-AAC1-4527-B235-394C92CF6770 @default.
- Q69906539 P356 JCEM-65-4-703 @default.
- Q69906539 P698 2888785 @default.
- Q69906539 P1433 Q3186902 @default.
- Q69906539 P1476 "SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years" @default.
- Q69906539 P2093 "Lamberts SW" @default.
- Q69906539 P2093 "Uitterlinden P" @default.
- Q69906539 P2093 "del Pozo E" @default.
- Q69906539 P304 "703-710" @default.
- Q69906539 P31 Q13442814 @default.
- Q69906539 P356 "10.1210/JCEM-65-4-703" @default.
- Q69906539 P407 Q1860 @default.
- Q69906539 P433 "4" @default.
- Q69906539 P478 "65" @default.
- Q69906539 P577 "1987-10-01T00:00:00Z" @default.
- Q69906539 P698 "2888785" @default.